Outcomes following primary percutaneous coronary intervention for unprotected left main-related ST-segment elevation

Alfonso Ielasi1, Antonio Silvestro, Davide Personeni

  • 1Department of Cardiology, Azienda Ospedaliera 'Bolognini', Seriate (BG), Italy *Drs Ielasi and Silvestro contributed equally to the manuscript and are joint first authors.

Insights

Primary percutaneous coronary intervention (PPCI) for unprotected left main (ULM) ST-segment elevation myocardial infarction (STEMI) is feasible without on-site surgery. Cardiogenic shock significantly increases in-hospital mortality, but survivors have excellent mid-term outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Unprotected left main (ULM) related ST-segment elevation myocardial infarction (STEMI) is a critical condition associated with high rates of circulatory failure and sudden cardiac death.
  • While outcomes for ULM thrombosis treated with primary percutaneous coronary intervention (PPCI) are known, data from hospitals without on-site surgical backup are limited.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of PPCI for ULM-related STEMI in a hospital setting lacking on-site surgical facilities.
  • To assess in-hospital mortality rates, particularly comparing patients with and without cardiogenic shock upon admission.

Main Methods:

  • A retrospective cohort analysis of consecutive patients undergoing PPCI for ULM-related STEMI at a single center.
  • Patients were stratified based on the presence or absence of cardiogenic shock at the time of admission.
  • Primary endpoint was in-hospital mortality.

Main Results:

  • Out of 1094 STEMI patients, 34 (3.1%) underwent PPCI for ULM-related STEMI; 22 (64.7%) were in cardiogenic shock.
  • Patients in cardiogenic shock had lower ejection fraction, higher prevalence of cardiac arrest, Killip Class III-IV, and poorer coronary flow.
  • In-hospital mortality was significantly higher in the cardiogenic shock group (36.4%) compared to the non-cardiogenic shock group (0%). Procedural success was also lower in the shock group (77.3% vs. 100%).

Conclusions:

  • PPCI for ULM-related STEMI is technically feasible in hospitals without on-site surgical backup.
  • Cardiogenic shock significantly impacts procedural success and in-hospital mortality.
  • Patients surviving the acute phase demonstrated excellent mid-term outcomes, irrespective of initial clinical severity.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.0K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
923
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
443